Monitoring Accumulating Data in a Clinical Trial
From MaRDI portal
Publication:3201535
DOI10.2307/2531771zbMath0715.62235OpenAlexW2008860560WikidataQ30976844 ScholiaQ30976844MaRDI QIDQ3201535
Publication date: 1989
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2531771
likelihoodsurvival analysisclinical trialBayes' theoremsequential analysisearly stoppinginterim analysisaccounting for patients' prognosescovariate analysis
Related Items (5)
Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design ⋮ BAYES DISCRETE SEQUENTIAL BOUNDARIES FOR CLINICAL TRIALS ⋮ Bayes optimal sequential trial designs ⋮ Nonmyopic and pseudo-nonmyopic approaches to optimal sequential design in the presence of covariates ⋮ A Bayesian Group Sequential Approach for Multiple Endpoints
This page was built for publication: Monitoring Accumulating Data in a Clinical Trial